查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲合成激素市场：依产品类型、给药途径、用途、最终用户和国家进行分析和预测（2023-2033）
市场调查报告书
商品编码
1501636

欧洲合成激素市场：依产品类型、给药途径、用途、最终用户和国家进行分析和预测（2023-2033）

Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 67 Pages | 商品交期: 1-5个工作天内

价格

欧洲合成荷尔蒙市场规模预计将从 2023 年的 49 亿美元成长到 2033 年的 105.3 亿美元，预测期内复合年增长率为 7.94%。

随着参与者开发创新的合成激素，合成激素市场正在不断成长。

主要市场统计数据
预测期 2023-2033
2023年评估 49亿美元
2033年预测 105.3亿美元
复合年增长率 7.94%

欧洲合成荷尔蒙市场的特点是积极的研发活动，旨在推进治疗方法和药物。该地区领先的製药公司正在积极致力于创新合成激素的开发和商业化，以解决各种医疗状况。该市场的推动因素包括医疗保健成本不断上升、甲状腺功能障碍和荷尔蒙相关癌症等荷尔蒙疾病的盛行率不断上升，以及医疗保健专业人员和患者对先进治疗方案的认识不断提高。监管支持和严格的品质标准也透过确保合成荷尔蒙产品的安全性和有效性进一步促进了市场成长。随着生物技术和製药科学的不断进步，欧洲仍然是开发和采用尖端合成荷尔蒙疗法的关键中心，为改善整个非洲大陆的患者治疗效果和医疗保健进步做出了贡献。

市场区隔

第 1 部分：依产品类型

  • 类固醇激素
  • 肽激素
  • 其他的

第 2 部分：依给药途径

  • 皮下的
  • 口服
  • 静脉内/肌肉内
  • 其他的

第 3 部分：按应用

  • 糖尿病
  • 生长激素缺乏症
  • 避孕
  • 男性性腺功能低下症
  • 停经
  • 其他的

第 4 部分：最终用户

  • 医院药房
  • 零售药房
  • 网路药房

第 5 部分：按国家划分

  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 其他的

该报告调查了欧洲合成激素市场，并提供了有关行业趋势、技术和专利趋势、法律制度、市场增长促进和限制因素、市场规模趋势和预测以及按各个细分市场和主要国家细分的主要企业。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
    • 趋势一：个人化合成荷尔蒙疗法
    • 趋势二：AI融合
  • 市场规模和成长潜力
  • 研发回顾
    • 专利公开趋势（按国家）
    • 专利公开趋势（按年份）
  • 监管状况
  • 市场动态：概述
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 区域

  • 区域概况
  • 促进因素/抑制因素
  • 欧洲
    • 市场成长推进因素
    • 市场问题
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的

第三章市场：竞争基准化分析/公司简介

  • 企业评价
    • Ferring BV
    • Novo Nordisk A/S
    • Ipsen Pharma
    • Novartis AG
    • Perrigo Company plc
    • Sanofi

第四章调查方法

Product Code: BHL2158SS

Introduction to Europe Synthetic Hormones Market

The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments anticipated from key market players focused on creating innovative synthetic hormones.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$4.90 Billion
2033 Forecast$10.53 Billion
CAGR7.94%

Market Introduction

The Europe synthetic hormones market is characterized by robust research and development activities aimed at advancing medical treatments and therapies. Key pharmaceutical companies across the region are actively engaged in developing and commercializing innovative synthetic hormones to address various medical conditions. This market is driven by increasing healthcare expenditure, rising prevalence of hormonal disorders such as thyroid dysfunction and hormone-related cancers, and growing awareness among healthcare professionals and patients about advanced treatment options. Regulatory support and stringent quality standards further bolster market growth by ensuring the safety and efficacy of synthetic hormone products. With ongoing advancements in biotechnology and pharmaceutical sciences, Europe continues to be a significant hub for the development and adoption of cutting-edge synthetic hormone therapies, contributing to improved patient outcomes and healthcare advancements across the continent.

Market Segmentation:

Segmentation 1: by Product Type

  • Steroid Hormones
  • Peptide Hormones
  • Others

Segmentation 2: by Route of Administration

  • Subcutaneous
  • Oral
  • Intravenous/Intramuscular
  • Others

Segmentation 3: by Application

  • Diabetes
  • Growth Hormone Deficiency
  • Contraception
  • Male Hypogonadism
  • Menopause
  • Others

Segmentation 4: by End User

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Segmentation 5: by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe synthetic hormones market (by product type) has been segmented based on product type, including peptide hormones, steroid hormones, and others. Moreover, the study provides the reader with a detailed understanding of the different routes of administration and application.

Growth/Marketing Strategy: To foster growth in the synthetic hormones market, a dual strategy focusing on research and development for safer, more effective formulations, alongside expanding outreach through strategic partnerships and education campaigns, is essential. Emphasizing personalized medicine and leveraging digital platforms for market expansion and patient engagement can also be pivotal in driving market growth and visibility.

Competitive Strategy: Key players in the Europe synthetic hormones market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the synthetic hormones market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in the market include:

  • Ferring B.V.
  • Novo Nordisk A/S
  • Ipsen Pharma
  • Novartis AG
  • Perrigo Company plc
  • Sanofi

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Trend 1: Personalized Synthetic Hormones Therapies
    • 1.1.2 Trend 2: Integration of Artificial Intelligence (AI)
  • 1.2 Market Footprint and Growth Potential, $Billion, 2022-2033
  • 1.3 Research and Development Review
    • 1.3.1 Patent Publishing Trend (by Country)
    • 1.3.2 Patent Publishing Trend (by Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
    • 1.5.2 Market Restraints
    • 1.5.3 Market Opportunities

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Driving Factors for Market Growth
    • 2.3.2 Factors Challenging the Market
    • 2.3.3 U.K.
    • 2.3.4 Germany
    • 2.3.5 France
    • 2.3.6 Italy
    • 2.3.7 Spain
    • 2.3.8 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Company Assessment
    • 3.1.1 Ferring B.V.
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Key Personnel
      • 3.1.1.5 Analyst View
    • 3.1.2 Novo Nordisk A/S
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Key Personnel
      • 3.1.2.5 Analyst View
    • 3.1.3 Ipsen Pharma
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Key Personnel
      • 3.1.3.5 Analyst View
    • 3.1.4 Novartis AG
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Key Personnel
      • 3.1.4.5 Analyst View
    • 3.1.5 Perrigo Company plc
      • 3.1.5.1 Overview
      • 3.1.5.2 Top Products
      • 3.1.5.3 Top Competitors
      • 3.1.5.4 Key Personnel
      • 3.1.5.5 Analyst View
    • 3.1.6 Sanofi
      • 3.1.6.1 Overview
      • 3.1.6.2 Top Products
      • 3.1.6.3 Top Competitors
      • 3.1.6.4 Key Personnel
      • 3.1.6.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Synthetic Hormones Optimistic, Pessimistic and Realistic Growth, 2023, 2027,2033
  • Figure 2: Synthetic Hormones Market (by Region), $Billion, 2022, 2027, and 2033
  • Figure 3: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022, 2027, and 2033
  • Figure 4: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022, 2027, and 2033
  • Figure 5: Key Events to Keep Track of within Synthetic Hormones Market
  • Figure 6: Benefits of Personalized Synthetic Hormone Therapies
  • Figure 7: AI Utilization in Synthetic Hormones
  • Figure 8: Europe Synthetic Hormones Market, $Billion, 2022-2033
  • Figure 9: Patent Published (by Country), January 2020-December 2023
  • Figure 10: Patent Published (by Year), January 2020-December 2023
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Trends in Occurrence of Diabetes, 2001-2020
  • Figure 13: Hormonal Disorders and their Prevalence Globally, 2020
  • Figure 14: Uptake of HRT Medicines and Prescribing Rate, Europe
  • Figure 15: Examples of a Few Technological Advancements
  • Figure 16: Factors Contributing to High Developmental Costs
  • Figure 17: Cost of Synthetic Hormone Therapy
  • Figure 18: Regulatory Process for Synthetic Hormones
  • Figure 19: Indications and Applications of Synthetic Hormones
  • Figure 20: Factors Contributing to Precision Medicine for Synthetic Hormones
  • Figure 21: Strategic Initiatives, 2021-2023
  • Figure 22: Data Triangulation
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Synthetic Hormones Market (by Region), $Billion, 2022-2033
  • Table 4: Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 5: Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 6: Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 7: Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 8: U.K. Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 9: U.K. Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 10: U.K. Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 11: U.K. Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 12: Germany Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 13: Germany Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 14: Germany Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 15: Germany Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 16: France Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 17: France Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 18: France Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 19: France Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 20: Italy Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 21: Italy Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 22: Italy Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 23: Italy Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 24: Spain Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 25: Spain Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 26: Spain Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 27: Spain Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 28: Rest-of-Europe Synthetic Hormones Market (by Product Type), $Billion, 2022-2033
  • Table 29: Rest-of-Europe Synthetic Hormones Market (by Route of Administration), $Billion, 2022-2033
  • Table 30: Rest-of-Europe Synthetic Hormones Market (by Application), $Billion, 2022-2033
  • Table 31: Rest-of-Europe Synthetic Hormones Market (by End User), $Billion, 2022-2033
  • Table 32: Market Share